2025 annual financial data
Arrowhead Pharmaceuticals 2025 Operating margin
Arrowhead Pharmaceuticals 2025 operating margin with verified reported values.
Direct answer
Operating margin was 11.86%.
Operating income was 98,346,000 USD and net income was -1,631,000 USD.
Operating cash flow was 179,552,000 USD.
Get free Arrowhead Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 829,448,000 USD
- Operating income
- 98,346,000 USD
- Net income
- -1,631,000 USD
- Operating cash flow
- 179,552,000 USD